Supplemental Table 3 from Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial
Year: 2024
Type: supplementary-materials
Abstract: Supplemental Table 3: Representativeness of Study Participants.
Authors: Tufia C. Haddad, Vera J. Suman, Karthik V. Giridhar, Kostandinos Sideras, Donald W. Northfelt, Brenda J. Ernst, Ciara C. O’Sullivan, Ravinder J. Singh, Zeruesenay Desta, Prema P. Peethambaram, Timothy J. Hobday, Saranya Chumsri, Roberto A. Leon-Ferre, Kathryn J. Ruddy, Siddhartha Yadav, Jodi L. Taraba, Barbara Goodnature, Matthew P. Goetz, Liewei Wang, James N. Ingle
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4401206191